-
Siegfried starts to ramp up production after cyber attack
cphi-online
June 02, 2021
Hameln plant which provides fill and finish for Pfizer-BioNTech COVID-19 shot should be fully operational within the week, CDMO says
-
Terry Gou to bid for Pfizer-BioNTech shots purchase before June 1
firstwordpharma
June 01, 2021
Taiwan, Chinaese billionaire businessman Terry Gou announced Sunday that he is putting together a bid to purchase the Pfizer-BioNTech COVID-19 vaccines for Taiwan, China that will be submitted within 72 hours, reported The China Post.
-
Ireland could start making Pfizer Covid vaccine as early as end of 2021
firstwordpharma
June 01, 2021
Ireland could start producing Pfizer’s COVID-19 vaccine as early as the end of this year, Independent.ie reported.
-
Pfizer jab less effective but still protects against Indian strain, study finds
firstwordpharma
May 31, 2021
According to a study by France’s Pasteur Institute, Pfizer’s COVID-19 vaccine is slightly less effective but appears to still protect against the more transmissible variant of the virus first identified in India, The Japan Times reported.
-
EU authorises Pfizer-BioNTech Covid-19 vaccine in adolescents
pharmaceutical-technology
May 31, 2021
Pfizer and BioNTech have received expanded Conditional Marketing Authorization (CMA) in the European Union (EU) for their Covid-19 vaccine, Comirnaty, to include people aged 12 to 15 years.
-
Pfizer Explors Coadministration of Its 20-valent Pneumococcal Vaccine With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine
americanpharmaceuticalreview
May 28, 2021
Pfizer announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the coadministration of the company’s 20-valent pneumococcal conjugate vaccine (20vPnC) candidate ...
-
FDA approves Pfizer, Myovant’s uterine fibroids drug Myfembree
pharmatimes
May 27, 2021
The US Food and Drug Administration (FDA) has approved Pfizer and Myovant’s uterine fibroids drug Myfembree for the management of heavy menstrual bleeding.
-
US clears Pfizer, Myovant's Myfembree for fibroid-associated menstrual bleeding
firstwordpharma
May 27, 2021
Pfizer and Myovant Sciences announced Wednesday that the FDA has approved Myfembree,which combines the GnRH antagonist relugolix with hormones estradiol and norethindrone, to manage heavy menstrual bleeding in premenopausal women who have uterine fibroids
-
India might get Moderna’s single-dose COVID-19 vaccine next year; Pfizer offers five crore shots in 2021
expresspharma
May 27, 2021
While Moderna has conveyed to Indian authorities that it does not have surplus vaccines to share in 2021, there are limited prospects of Johnson & Johnson exporting its jabs from the US to other countries in the near future.
-
Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Indian Variant: Study
drugs
May 25, 2021
Two doses of the Pfizer and AstraZeneca COVID-19 vaccines are effective against the coronavirus variant first identified in India, according to a new report from Public Health England.